AI Chatbot Shows Potential as Diagnostic Partner

Physician-investigators at Beth Israel Deaconess Medical Center (BIDMC) compared a chatbot's probabilistic reasoning to that of human clinicians. The findings, published in JAMA Network Open, suggest that artificial intelligence could serve as useful clinical decision support tools for physicians.

"Humans struggle with probabilistic reasoning, the practice of making decisions based on calculating odds," said the study's corresponding author Adam Rodman, MD, an internal medicine physician and investigator in the department of Medicine at BIDMC. "Probabilistic reasoning is one of several components of making a diagnosis, which is an incredibly complex process that uses a variety of different cognitive strategies. We chose to evaluate probabilistic reasoning in isolation because it is a well-known area where humans could use support."

Basing their study on a previously published national survey of more than 550 practitioners performing probabilistic reasoning on five medical cases, Rodman and colleagues fed the publicly available Large Language Model (LLM), Chat GPT-4, the same series of cases and ran an identical prompt 100 times to generate a range of responses.

The chatbot - just like the practitioners before them - was tasked with estimating the likelihood of a given diagnosis based on patients' presentation. Then, given test results such as chest radiography for pneumonia, mammography for breast cancer, stress test for coronary artery disease and a urine culture for urinary tract infection, the chatbot program updated its estimates.

When test results were positive, it was something of a draw; the chatbot was more accurate in making diagnoses than the humans in two cases, similarly accurate in two cases and less accurate in one case. But when tests came back negative, the chatbot shone, demonstrating more accuracy in making diagnoses than humans in all five cases.

"Humans sometimes feel the risk is higher than it is after a negative test result, which can lead to overtreatment, more tests and too many medications," said Rodman.

But Rodman is less interested in how chatbots and humans perform toe-to-toe than in how highly skilled physicians' performance might change in response to having these new supportive technologies available to them in the clinic, added Rodman. He and colleagues are looking into it.

"LLMs can't access the outside world - they aren't calculating probabilities the way that epidemiologists, or even poker players, do. What they're doing has a lot more in common with how humans make spot probabilistic decisions," he said. "But that's what is exciting. Even if imperfect, their ease of use and ability to be integrated into clinical workflows could theoretically make humans make better decisions," he said. "Future research into collective human and artificial intelligence is sorely needed."

Rodman A, Buckley TA, Manrai AK, Morgan DJ.
Artificial Intelligence vs Clinician Performance in Estimating Probabilities of Diagnoses Before and After Testing.
JAMA Netw Open. 2023 Dec 1;6(12):e2347075. doi: 10.1001/jamanetworkopen.2023.47075

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...